Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.35895
Publication URI: https://www.repository.cam.ac.uk/handle/1810/288612
Type: Journal Article/Review